Markets › LSE › 0HNC.L

BioMarin Pharmaceutical Inc.

LSE:0HNC.LHealthcare

——At close · Market cap — · Next earnings Mon 26 Oct

Beat (%) vs consensus · next report Mon 26 Oct

DateMon, 26 Oct 2026

EPS estimate1.36

Revenue estimate1,033.0m

Currency—

Report	EPS estimate	EPS actual	EPS surprise	Revenue estimate (m)	Revenue actual (m)	Revenue surprise
2026-08-06	0.95	1.20	+26.7%	932.0	989.7	+6.2%
2026-05-04	0.69	0.76	+9.8%	752.5	766.0	+1.8%
2026-02-23	0.17	−0.24	−241.7%	833.7	874.6	+4.9%
2025-10-27	−0.28	−0.16	+42.8%	834.3	776.1	−7.0%
2025-08-04	0.86	1.22	+41.7%	806.6	827.5	+2.6%
2025-05-01	0.68	0.95	+39.3%	762.4	745.1	−2.3%
2025-02-19	0.53	0.64	+19.1%	728.7	738.2	+1.3%
2024-10-30	0.53	0.54	+1.3%	712.3	745.7	+4.7%
2024-08-06	0.36	0.54	+49.5%	664.0	712.0	+7.2%
2024-04-25	0.31	0.45	+42.7%	651.8	650.0	−0.3%
2024-03-05	0.20	0.11	−46.1%	638.8	645.9	+1.1%
2023-11-02	0.22	0.21	−3.8%	603.8	586.0	−3.0%

Currency not supplied by the earnings feedUpdated Thu 6 Aug ·

ⓘ

Surprise is actual minus consensus, as a share of the consensus.